Dr. Anna Pavlick discusses targeted therapy, specifically hedgehog inhibitors for basal cell cancers, explaining how these therapies block cancer growth pathways, their rapid effectiveness, and potential side effects.

Dr. Anna Pavlick is a medical oncologist and the founding Director of the Cutaneous Oncology Program at Weill Cornell Medicine and NewYorkPresbyterian. Learn more about this expert.

Patient Empowerment Network (PEN) is a 501(c)(3) nonprofit organization. PEN’s mission is to offer trusted information to empower anyone impacted by cancer, through health equity, health literacy and shared decisionmaking. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect